AKESO News

AKESO: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2024

Nov 4 05:04 ET

AKESO: Next Day Disclosure Return

Oct 21 09:31 ET

AKESO: COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE

Oct 21 09:26 ET

AKESO: PLACING OF NEW SHARES UNDER GENERAL MANDATE

Oct 13 07:52 ET

AKESO: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2024

Oct 3 04:11 ET

AKESO: VOLUNTARY ANNOUNCEMENT - NMPA APPROVED THE NEW DRUG APPLICATION OF (EBRONUCIMAB, PCSK9)

Sep 30 10:19 ET

AKESO: VOLUNTARY ANNOUNCEMENT - NMPA APPROVED THE SNDA OF (CADONILIMAB, PD-1/CTLA-4)IN COMBINATION WITH CHEMOTHERAPYAS A FIRST-LINE TREATMENT FOR GASTRIC CANCER

Sep 30 10:16 ET

AKESO: 2024 INTERIM REPORT

Sep 30 04:46 ET

AKESO: VOLUNTARY ANNOUNCEMENT - PFS HR 0.51, MPFS 11.14 MONTHSIVONESCIMAB MONOTHERAPY VS PEMBROLIZUMABAS 1L TREATMENT OF PD-L1 POSITIVE NSCLC(AK112-303/HARMORNI-2) PHASE III RESULTSPUBLISHED AT 2024 WCLC

Sep 8 18:32 ET

AKESO: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 August 2024

Sep 3 05:00 ET

AKESO: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024

Aug 28 09:56 ET

AKESO: DATE OF BOARD MEETING

Aug 16 06:00 ET

AKESO: VOLUNTARY ANNOUNCEMENT - AK112-303/HARMONI-2 WAS ACCEPTED AS LBA OF 2024 WCLCPRESIDENTIAL SYMPOSIUM ORAL PRESENTATION

Aug 11 19:42 ET

AKESO: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2024

Aug 5 04:05 ET

AKESO: VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTED THE SUPPLEMENTAL NEW DRUG APPLICATIONFOR IVONESCIMAB (PD-1/VEGF) MONOTHERAPY AS FIRST-LINETREATMENT FOR NSCLC WITH POSITIVE PD-L1 EXPRESSION

Jul 30 08:03 ET

AKESO: APPOINTMENT OF CHIEF FINANCIAL OFFICER

Jul 21 20:15 ET

AKESO: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2024

Jul 5 00:36 ET

AKESO: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

Jul 1 06:28 ET

AKESO: CHANGE OF DIRECTORS

Jul 1 06:26 ET

AKESO: POLL RESULTS OF THE ANNUAL GENERAL MEETINGHELD ON SUNDAY, JUNE 30, 2024

Jul 1 06:21 ET